HKSE - Delayed Quote HKD
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK)
299.800
+1.200
+(0.40%)
As of 11:59:50 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-429,770
-429,770
59,559
-270,847
-485,942
Investing Cash Flow
-822,005
-822,005
-1,025,417
-32,150
-94,384
Financing Cash Flow
1,037,219
1,037,219
2,382,281
313,452
647,316
End Cash Position
1,336,503
1,336,503
1,528,774
92,960
81,793
Capital Expenditure
-81,119
-81,119
-82,250
-38,992
-94,743
Issuance of Capital Stock
1,094,108
1,094,108
2,853,095
--
533,811
Issuance of Debt
--
--
--
363,000
225,484
Repayment of Debt
--
--
-394,040
-45,000
-70,000
Free Cash Flow
-510,889
-510,889
-22,691
-309,839
-580,685
12/31/2021 - 7/11/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2563.HK Beijing Biostar Pharms Co Ltd
4.410
-17.42%
1952.HK Everest Medicines Limited
46.450
-6.54%
9966.HK Alphamab Oncology
6.980
-4.64%
9688.HK Zai Lab Limited
25.850
-0.58%
6160.HK BeiGene, Ltd.
151.000
-0.33%
1530.HK 3SBIO
12.900
+0.78%
1548.HK GENSCRIPT BIO
11.160
+1.09%
9995.HK RemeGen Co., Ltd.
38.250
+8.36%
2696.HK Shanghai Henlius Biotech, Inc.
38.650
+2.52%
1177.HK SINO BIOPHARM
3.860
+0.52%